1. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55:181–184.
![crossref](/image/icon/bnr_ref_cross.gif)
2. Yust-Katz S, Tesler D, Treves TA, Melamed E, Djaldetti R. Handedness as a predictor of side of onset of Parkinson’s disease. Parkinsonism Relat Disord. 2008; 14:633–635.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease: handedness predicts asymmetry. Neurology. 2005; 64:1925–1930.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Kempster PA, Gibb WR, Stern GM, Lees AJ. Asymmetry of substantia nigra neuronal loss in Parkinson’s disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry. 1989; 52:72–76.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, et al. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol. 2005; 57:176–179.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci. 2001; 21:4427–4435.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem. 2003; 85:299–305.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Kim JS, Yang JJ, Lee JM, Youn J, Kim JM, Cho JW. Topographic pattern of cortical thinning with consideration of motor laterality in Parkinson disease. Parkinsonism Relat Disord. 2014; 20:1186–1190.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Kang Y, Jang S, Na DL. Seoul Neuropsychological Screening Battery (SNSB-II). 2nd ed. Seoul: Human Brain Research & Consulting Co.;2012.
10. Cronin-Golomb A. Parkinson’s disease as a disconnection syndrome. Neuropsychol Rev. 2010; 20:191–208.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Chapman LF, Wolff HG. The cerebral hemispheres and the highest integrative functions of man. Arch Neurol. 1959; 1:357–424.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Agniel A, Celsis P, Viallard G, Montastruc JL, Rascol O, Demonet JF, et al. Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. J Neurol Neurosurg Psychiatry. 1991; 54:783–786.
![crossref](/image/icon/bnr_ref_cross.gif)
13. St Clair J, Borod JC, Sliwinski M, Cote LJ, Stern Y. Cognitive and affective functioning in Parkinson’s disease patients with lateralized motor signs. J Clin Exp Neuropsychol. 1998; 20:320–327.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Huber SJ, Miller H, Bohaska L, Christy JA, Bornstein RA. Asymmetrical cognitive differences associated with hemiparkinsonism. Arch Clin Neuropsychol. 1992; 7:471–480.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Starkstein S, Leiguarda R, Gershanik O, Berthier M. Neuropsychological disturbances in hemiparkinson’s disease. Neurology. 1987; 37:1762–1764.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Hale JB, Hoeppner JAB, Fiorello CA. Analyzing digit span components for assessment of attention processes. J Psychoeduc Assess. 2002; 20:128–143.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Erro R, Santangelo G, Picillo M, Vitale C, Amboni M, Longo K, et al. Side of onset does not influence cognition in newly diagnosed untreated Parkinson’s disease patients. Parkinsonism Relat Disord. 2013; 19:256–259.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Oyebode JR, Barker WA, Blessed G, Dick DJ, Britton PG. Cognitive functioning in Parkinson’s disease: in relation to prevalence of dementia and psychiatric diagnosis. Br J Psychiatry. 1986; 149:720–725.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Cooper CA, Mikos AE, Wood MF, Kirsch-Darrow L, Jacobson CE, Okun MS, et al. Does laterality of motor impairment tell us something about cognition in Parkinson disease? Parkinsonism Relat Disord. 2009; 15:315–317.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Kim JS, Lee KH, Lee SJ, Song IU, Kim YI, Lee KS. The pattern of cognitive impairment associated with the motor subtype in Parkinson’s disease. J Korean Geriatr Soc. 2008; 12:227–234.
21. Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev. 2000; 31:236–250.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Trépanier LL, Saint-Cyr JA, Lozano AM, Lang AE. Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson’s disease. Neurology. 1998; 51:207–215.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Cohen JD, Forman SD, Braver TS, Casey BJ, Servan-Schreiber D, Noll DC. Activation of the prefrontal cortex in a nonspatial working memory task with functional MRI. Hum Brain Mapp. 1994; 1:293–304.
![crossref](/image/icon/bnr_ref_cross.gif)
24. Fiez JA, Raife EA, Balota DA, Schwarz JP, Raichle ME, Petersen SE. A positron emission tomography study of the short-term maintenance of verbal information. J Neurosci. 1996; 16:808–822.
![crossref](/image/icon/bnr_ref_cross.gif)